FDA Orange Book
Generic for Sandostatin Lar
Sandostatin Lar contains octreotide acetate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Sandostatin Lar is octreotide acetate. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Sandostatin Lar and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Sandostatin Lar products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, injection | EQ 10MG BASE/VIAL | Marketed (Rx) | AB | 2 | AB |
| injectable, injection | EQ 20MG BASE/VIAL | Marketed (Rx) | AB | 2 | AB |
| injectable, injection | EQ 30MG BASE/VIAL | Marketed (Rx) | AB | 2 | AB |
NDA 021008, held by NOVARTIS PHARMACEUTICALS CORP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic octreotide acetate
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA INC | 210317 | AB (A-rated, therapeutically equivalent) | December 5, 2023 | EQ 10MG BASE/VIAL, EQ 20MG BASE/VIAL, EQ 30MG BASE/VIAL |
| MYLAN LABORATORIES LTD | 216589 | AB (A-rated, therapeutically equivalent) | December 12, 2025 | EQ 10MG BASE/VIAL, EQ 20MG BASE/VIAL, EQ 30MG BASE/VIAL |
Questions
Is there a generic for Sandostatin Lar?
Yes. The generic name for Sandostatin Lar is octreotide acetate. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Sandostatin Lar?
The active ingredient in Sandostatin Lar is octreotide acetate, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.